Implementing a Dual Screening Protocol for Diabetes and Frailty in a Community-Dwelling Older Adults
DOI:
10.29303/ujcs.v6i3.1157Published:
2025-09-30Issue:
Vol. 6 No. 3 (2025): SeptemberKeywords:
Diabetes, Frailty, Elderly, CommunityArticles
Downloads
How to Cite
Downloads
Metrics
Abstract
Frailty, a significant geriatric syndrome, is a major complication of diabetes and is associated with adverse health outcomes. Indonesia, with its rapidly aging population, faces a substantial burden from these conditions. Community-based screening is essential for early detection and intervention. A community engagement program was conducted in Gunung Anyar District, Surabaya, involving 189 elderly participants. Simultaneous screenings for diabetes (via random blood glucose test) and frailty (using the validated FRAIL questionnaire) were performed. The study revealed a high dual burden of disease: 42.0% of participants had blood glucose levels indicative of diabetes, while 11.6% were classified as frail and 39.7% as pre-frail. About 30% of them were both unfit and poor glycemic control. This program demonstrates a high prevalence of diabetes and frailty among community-dwelling older adults in Surabaya, underscoring the urgent need for integrated geriatric care. The successful implementation of dual screening highlights the feasibility of incorporating these measures into primary care and the critical role of training community health workers to enable sustainable, early detection and management strategies.
References
Badrkhahan, S. Z., Ala, M., Fakhrzadeh, H., Yaghoobi, A., Mirzamohamadi, S., Arzaghi, S. M., Shahabi, S., Sharifi, F., Ostovar, A., Fahimfar, N., Nabipour, I., Larijani, B., Shafiee, G., & Heshmat, R. (2023). The prevalence and predictors of geriatric giants in community-dwelling older adults: A cross-sectional study from the Middle East. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-39614-4
Bu, F., Deng, X. hui, Zhan, N. ni, Cheng, H., Wang, Z. lin, Tang, L., Zhao, Y., & Lyu, Q. yuan. (2023). Development and validation of a risk prediction model for frailty in patients with diabetes. BMC Geriatrics, 23(1). https://doi.org/10.1186/s12877-023-03823-3
Elmaleh, D. M., & Mohamed, D. M. A. (2025). Sarcopenia and frailty as predictor of outcome in critically ill elderly patients with multiple comorbidities. The Egyptian Journal of Internal Medicine, 37(1), 3. https://doi.org/10.1186/s43162-024-00388-4
Gleason, L. J., Benton, E. A., Alvarez-Nebreda, M. L., Weaver, M. J., Harris, M. B., & Javedan, H. (2017). FRAIL questionnaire screening tool and short-term outcomes in geriatric fracture patients. Journal of the American Medical Directors Association, 18(12), 1082–1086. https://doi.org/10.1016/j.jamda.2017.07.005
Kementerian Kesehatan. (2018). Laporan nasional Riskesdas 2018. https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan%20Riskesdas%202018%20Nasional.pdf
Mei, F., Gao, Q., Chen, F., Zhao, L., Shang, Y., Hu, K., Zhang, W., Zhao, B., & Ma, B. (2021). Frailty as a predictor of negative health outcomes in chronic kidney disease: A systematic review and meta-analysis. Journal of the American Medical Directors Association 22(3), 535-543.e7. https://doi.org/10.1016/j.jamda.2020.09.033
Zi, L. O. H., Susanty, S., & Suhadi, S. (2025). Factors associated with type 2 diabetes mellitus in older adults living in coastal areas: Implications for community nursing practice. Jurnal Keperawatan Padjadjaran, 13(2), 219–228. https://doi.org/10.24198/jkp
Pradana, A. A., Chiu, H. L., Lin, C. J., & Lee, S. C. (2023). Prevalence of frailty in Indonesia: A systematic review and meta-analysis. BMC Geriatrics, 23(1). https://doi.org/10.1186/s12877-023-04468-y
Setiati, S., Laksmi, P. W., Aryana, I. G. P. S., Sunarti, S., Widajanti, N., Dwipa, L., Seto, E., Istanti, R., Ardian, L. J., & Chotimah, S. C. (2019). Frailty state among Indonesian elderly: Prevalence, associated factors, and frailty state transition. BMC Geriatrics, 19(1). https://doi.org/10.1186/s12877-019-1198-8
Sukkriang, N., & Punsawad, C. (2020). Comparison of geriatric assessment tools for frailty among community elderly. Heliyon, 6(9). https://doi.org/10.1016/j.heliyon.2020.e04797
United Nations. (2019). World Population Ageing 2019. In United Nations, Department of Economic and Social Affairs, Population Division.
Vermeiren, S., Vella-Azzopardi, R., Beckwée, D., Habbig, A. K., Scafoglieri, A., Jansen, B., Bautmans, I., Bautmans, I., Verté, D., Beyer, I., Petrovic, M., De Donder, L., Kardol, T., Rossi, G., Clarys, P., Scafoglieri, A., Cattrysse, E., de Hert, P., & Jansen, B. (2016). Frailty and the prediction of negative health outcomes: A meta-analysis. Journal of the American Medical Directors Association 17(12), 1163.e1-1163.e17). https://doi.org/10.1016/j.jamda.2016.09.010
Wu, Y., Xiong, T., Tan, X., & Chen, L. (2022). Frailty and risk of microvascular complications in patients with type 2 diabetes: A population-based cohort study. BMC Medicine, 20(1). https://doi.org/10.1186/s12916-022-02675-9
Author Biographies
Laurentius Johan Ardian, Universitas Pembangunan Nasional Veteran Jawa Timur
Aktaruddin Arief Santoso, Universitas Pembangunan Nasional Veteran Jawa Timur
Hilmia Fahma, Universitas Pembangunan Nasional Veteran Jawa Timur
Anoraga Mona Cinta Gadis Cantika Gusyono, Universitas Pembangunan Nasional Veteran Jawa Timur
Satria Fudi Verbimanto, Universitas Pembangunan Nasional Veteran Jawa Timur
License
Copyright (c) 2025 Laurentius Johan Ardian, Aktaruddin Arief Santoso, Hilmia Fahma, Anoraga Mona Cinta Gadis Cantika Gusyono, Satria Fudi Verbimanto

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.